SMS Medical College (IN)
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
88
Publications
1405
Citations
40140
i10-index
425
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Olaparib for Metastatic Castration-Resistant Prost... | 2020 | 2580 |
Clinical impact of COVID-19 on patients with cance... | 2020 | 1850 |
Apalutamide for Metastatic, Castration-Sensitive P... | 2019 | 1712 |
Ipilimumab versus placebo after radiotherapy in pa... | 2014 | 1598 |
External validation and comparison with other mode... | 2013 | 1146 |
Cabozantinib versus everolimus in advanced renal c... | 2016 | 1048 |
Survival with Olaparib in Metastatic Castration-Re... | 2020 | 880 |
Kidney Cancer, Version 3.2022, NCCN Clinical Pract... | 2022 | 748 |
Kidney Cancer, Version 2.2017, NCCN Clinical Pract... | 2017 | 617 |
Talazoparib plus enzalutamide in men with first-li... | 2023 | 607 |
Neeraj Agarwal is a researcher with 1405 publications and 40140 citations. They are affiliated with SMS Medical College. Their research focuses on Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Renal cell carcinoma treatment and other areas. With an h-index of 88, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Neeraj Agarwal and 300M+ other papers.
Citations per publication by year